Genetic correction of cultured T cells from an adenosine deaminase‐deficient patient: Characteristics of non‐transduced and transduced T cells
作者:
Eric Braakman,
Victor W. Van Beusechem,
Brigitte A. Van Krimpen,
Alain Fischer,
Reinder L. H. Bolhuis,
Dinko Valerio,
期刊:
European Journal of Immunology
(WILEY Available online 1992)
卷期:
Volume 22,
issue 1
页码: 63-69
ISSN:0014-2980
年代: 1992
DOI:10.1002/eji.1830220111
出版商: WILEY‐VCH Verlag GmbH
数据来源: WILEY
摘要:
AbstractT lymphocytes derived from peripheral blood of a patient with adenosine deaminase (ADA) deficiency were expandedin vitro. The human ADA (hADA) gene was introduced into these replicating ADA−T cells with the use of an amphotropic recombinant retrovirus carrying the hADA gene. Subsequently, infected T cells were selected on the basis of their ADA expression, by exposure to a combination of the toxic agent xylofuranosyl‐adenine and the specific ADA inhibitor 2′‐deoxycoformycin. CD4+and CD8+T cells could be infected and selected with equal efficiencies. The genetically modified T cells were shown to contain intact copies of the provirus and to express normal levels of hADA. As expected, uninfected T cells from the ADA‐deficient patient displayed an increased sensitivity to 2′‐deoxyadenosine. Following genetic modification, however, this sensitivity was restored to normal levels in both CD4+and CD8+T cells. The introduction of the hADA gene into the genome of thein vitroexpanded T cells did not alter their phenotype, proliferative capacity or cytotoxic potential. These characteristics were identical to those of T cells derived from healthy individuals. These findings are of critical importance for the clinical application of hADA gene‐tran
点击下载:
PDF
(723KB)
返 回